Related Experiment Videos

[Medroxyprogesterone acetate (MPA) in the treatment of advanced breast cancer]

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|August 1, 1987

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effects of medroxyprogesterone acetate therapy on advanced or recurrent breast cancer and its influences on blood coagulation and the fibrinolytic system.

Surgery today·1995

Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer.

European journal of cancer (Oxford, England : 1990)·1994

[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1994

Changing practices in the surgical treatment of breast cancer in Japan: a nationwide survey by the Japanese Breast Cancer Society.

Surgery today·1994

[Correlations between estrogen receptor and prognostic factors of patients with breast cancer. The Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan].

Gan to kagaku ryoho. Cancer & chemotherapy·1993

A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.

Anticancer research·1993

See all related articles